Cystic fibrosis

被引：150

作者：

Rosenstein, BJ ^{[1
]}

Zeitlin, PL ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

来源：

LANCET | 1998年 / 351卷 / 9098期

关键词：

D O I：

10.1016/S0140-6736(97)09174-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：277 / 282

页数：6

共 83 条

[1]

ALTON EWFW, 1990, EUR RESPIR J, V3, P922

[2] The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome [J].

Aris, RM ;

Gilligan, PH ;

Neuringer, IP ;

Gott, KK ;

Rea, J ;

Yankaskas, JR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (05) :1699-1704

[3] Heart-lung transplantation for patients under 10 with cystic fibrosis [J].

BalfourLynn, IM ;

Martin, I ;

Whitehead, BF ;

Rees, PG ;

Elliott, MJ ;

deLeval, MR .

ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (01) :38-40

[4] Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].

Bellon, G ;

MichelCalemard, L ;

Thouvenot, D ;

Jagneaux, V ;

Poitevin, F ;

Malcus, C ;

Accart, N ;

Layani, MP ;

Aymard, M ;

Bernon, H ;

Bienvenu, J ;

Courtney, M ;

Doring, G ;

Gilly, B ;

Gilly, R ;

Lamy, D ;

Levrey, H ;

Morel, Y ;

Paulin, C ;

Perraud, F ;

Rodillon, L ;

Sene, C ;

So, S ;

TouraineMoulin, F ;

Schatz, C ;

Pavirani, A .

HUMAN GENE THERAPY, 1997, 8 (01) :15-25

[5] GENE-THERAPY FOR CYSTIC-FIBROSIS USING E1-DELETED ADENOVIRUS - A PHASE-I TRIAL IN THE NASAL CAVITY - THE UNIVERSITY-OF-NORTH-CAROLINA AT CHAPEL-HILL [J].

BOUCHER, RC ;

KNOWLES, MR ;

JOHNSON, LG ;

OLSEN, JC ;

PICKLES, R ;

WILSON, JM ;

ENGELHARDT, J ;

YANG, YP ;

GROSSMAN, M .

HUMAN GENE THERAPY, 1994, 5 (05) :615-639

[6] Correcting temperature-sensitive protein folding defects [J].

Brown, CR ;

HongBrown, LQ ;

Welch, WJ .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1432-1444

[7] VARIABLE SEVERITY OF PULMONARY-DISEASE IN ADULTS WITH IDENTICAL CYSTIC-FIBROSIS MUTATIONS [J].

BURKE, W ;

AITKEN, ML ;

CHEN, SH ;

SCOTT, CR .

CHEST, 1992, 102 (02) :506-509

[8] DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS [J].

CHENG, SH ;

GREGORY, RJ ;

MARSHALL, J ;

PAUL, S ;

SOUZA, DW ;

WHITE, GA ;

ORIORDAN, CR ;

SMITH, AE .

CELL, 1990, 63 (04) :827-834

[9] FUNCTIONAL ACTIVATION OF THE CYSTIC-FIBROSIS TRAFFICKING MUTANT DELTA-F508-CFTR BY OVEREXPRESSION [J].

CHENG, SH ;

FANG, SL ;

ZABNER, J ;

MARSHALL, J ;

PIRAINO, S ;

SCHIAVI, SC ;

JEFFERSON, DM ;

WELSH, MJ ;

SMITH, AE .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (04) :L615-L624

[10] MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].

CHILLON, M ;

CASALS, T ;

MERCIER, B ;

BASSAS, L ;

LISSENS, W ;

SILBER, S ;

ROMEY, MC ;

RUIZROMERO, J ;

VERLINGUE, C ;

CLAUSTRES, M ;

NUNES, V ;

FEREC, C ;

ESTIVILL, X .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480

← 1 2 3 4 5 6 7 8 9 →